Your request to link to rcsb for Bifunctional%20epoxide%20hydrolase%202

• 1S8O: human soluble epoxide hydrolase (10.1021/BI036189J )
• 1VJ5: human soluble epoxide hydrolase- n-cyclohexyl-n'-(4-iodophenyl)urea complex (10.1021/BI036189J )
• 1ZD2: human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)- ethanoic acid complex (10.1110/PS.051720206 )
• 1ZD3: human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)- butyric acid complex (10.1110/PS.051720206 )
• 1ZD4: human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)-hexanoic acid complex (10.1110/PS.051720206 )
• 1ZD5: human soluble epoxide hydrolase 4-(3-cyclohexyluriedo)- heptanoic acid complex (10.1110/PS.051720206 )
• 3ANS: human soluble epoxide hydrolase in complex with a synthetic inhibitor (10.1021/JM101273E )
• 3ANT: human soluble epoxide hydrolase in complex with a synthetic inhibitor (10.1021/JM101273E )
• 3I1Y: crystal structure of soluble epoxide hydrolase (10.1021/JM9005302 )
• 3I28: crystal structure of soluble epoxide hydrolase (10.1021/JM9005302 )
• 3KOO: crystal structure of soluble epoxide hydrolase (10.1016/J.BMCL.2009.11.091 )
• 3OTQ: soluble epoxide hydrolase in complex with pyrazole antagonist (10.1016/J.BMCL.2010.09.095 )
• 3PDC: crystal structure of hydrolase domain of human soluble epoxide hydrolase complexed with a benzoxazole inhibitor (10.1021/JM101382T )
• 3WK4: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WK5: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WK6: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WK7: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WK8: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WK9: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WKA: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WKB: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WKC: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WKD: crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor (10.1016/J.BMC.2014.03.001 )
• 3WKE: crystal structure of soluble epoxide hydrolase in complex with t-aucb (10.1016/J.BMC.2014.03.001 )
• 4C4X: crystal structure of human bifunctional epoxide hydroxylase 2 complexed with c9 (10.1002/ANIE.201500671 )
• 4C4Y: crystal structure of human bifunctional epoxide hydroxylase 2 complexed with a4 (10.1002/ANIE.201500671 )
• 4C4Z: crystal structure of human bifunctional epoxide hydroxylase 2 complexed with a8 (10.1002/ANIE.201500671 )
• 4HAI: crystal structure of human soluble epoxide hydrolase complexed with n- cycloheptyl-1-(mesitylsulfonyl)piperidine-4-carboxamide. (10.1016/J.BMCL.2012.11.084 )
• 4J03: crystal structure of human soluble epoxide hydrolase complexed with fulvestrant (10.1016/J.BMCL.2013.04.083 )
• 4JNC: soluble epoxide hydrolase complexed with a carboxamide inhibitor (10.1016/J.BMCL.2013.04.019 )
• 4OCZ: crystal structure of human soluble epoxide hydrolase complexed with 1- (1-isobutyrylpiperidin-4-yl)-3-(4-(trifluoromethyl)phenyl)urea (10.1021/JM500694P )
• 4OD0: crystal structure of human soluble epoxide hydrolase complexed with 1- (1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (10.1021/JM500694P )
• 4X6X: human soluble epoxide hydrolase in complex with a three substituted cyclopropane derivative (10.1016/J.BMCL.2015.02.076 )
• 4X6Y: human soluble epoxide hydrolase in complex with a cyclopropyl urea derivative (10.1016/J.BMCL.2015.02.076 )
• 4Y2J: structure of soluble epoxide hydrolase in complex with n-[(1-methyl- 1h-pyrazol-3-yl)methyl]-2-phenylethanamine (10.1016/J.BMC.2015.03.083 )
• 4Y2P: structure of soluble epoxide hydrolase in complex with n-methyl-1-[3- (pyridin-3-yl)phenyl]methanamine (10.1016/J.BMC.2015.03.083 )
• 4Y2Q: structure of soluble epoxide hydrolase in complex with 1-[3- (trifluoromethyl)pyridin-2-yl]piperazine (10.1016/J.BMC.2015.03.083 )
• 4Y2R: structure of soluble epoxide hydrolase in complex with 2-(piperazin-1- yl)nicotinonitrile (10.1016/J.BMC.2015.03.083 )
• 4Y2S: structure of soluble epoxide hydrolase in complex with 1-[3- (trifluoromethyl)phenyl]-1h-pyrazol-4-ol (10.1016/J.BMC.2015.03.083 )
• 4Y2T: structure of soluble epoxide hydrolase in complex with 3-[4- (benzyloxy)phenyl]propan-1-ol (10.1016/J.BMC.2015.03.083 )
• 4Y2U: structure of soluble epoxide hydrolase in complex with tert-butyl 1,2, 3,4-tetrahydroquinolin-3-ylcarbamate (10.1016/J.BMC.2015.03.083 )
• 4Y2V: structure of soluble epoxide hydrolase in complex with (4-bromo-3- cyclopropyl-1h-pyrazol-1-yl)acetic acid (10.1016/J.BMC.2015.03.083 )
• 4Y2X: structure of soluble epoxide hydrolase in complex with 2-({[2- (adamantan-1-yl)ethyl]amino}methyl)phenol (10.1016/J.BMC.2015.03.083 )
• 4Y2Y: structure of soluble epoxide hydrolase in complex with 2-(2- fluorophenyl)-n-[(5-methyl-2-thienyl)methyl]ethanamine (10.1016/J.BMC.2015.03.083 )
• 5AHX: apo structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AI0: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AI4: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AI5: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AI6: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AI8: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AI9: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AIA: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AIB: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AIC: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AK3: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AK4: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AK5: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AK6: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKE: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKG: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKH: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKI: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKJ: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKK: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKL: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKX: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKY: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AKZ: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALD: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALE: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALF: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALG: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALH: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALI: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALJ: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALK: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALL: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALM: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALN: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALO: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALP: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALQ: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALR: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALS: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALT: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALU: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALV: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALW: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALX: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALY: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5ALZ: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AM0: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AM1: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AM2: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AM3: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AM4: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5AM5: ligand complex structure of soluble epoxide hydrolase (10.1016/J.DRUDIS.2015.04.005 )
• 5FP0: ligand complex structure of soluble epoxide hydrolase (10.1002/CMDC.201500575 )
• 5MWA: human seh phosphatase in complex with 3-4-3,4-dichlorophenyl-5-phenyl- 1,3-oxazol-2-yl-benzoic-acid (10.1021/ACS.JMEDCHEM.9B00445 )
• 6AUM: crystal structure of human soluble epoxide hydrolase complexed with trans-4-[4-(3-trifluoromethoxyphenyl-l-ureido)-cyclohexyloxy]-benzoic acid. (10.1016/J.BMCL.2018.01.003 )
• 6FR2: soluble epoxide hydrolase in complex with lk864 (10.1016/J.BIOORG.2018.07.014 )
• 6HGV: soluble epoxide hydrolase in complex with talinolol (10.1021/ACSMEDCHEMLETT.9B00075 )
• 6HGW: soluble epoxide hydrolase in complex with 2-(4-fluorophenyl)-n-(4- phenoxybenzyl)ethanamine
• 6HGX: soluble epoxide hydrolase in complex with 1-(4-((4-(tert-butyl) morpholin-2-yl)methoxy)phenyl)-3-cyclohexylurea (10.1021/ACSMEDCHEMLETT.9B00075 )
• 6I5E: x-ray structure of apo human soluble epoxide hydrolase c-terminal domain (hseh ctd) (10.1038/S42003-019-0426-2 )
• 6I5G: x-ray structure of human soluble epoxide hydrolase c-terminal domain (hseh ctd)in complex with 15d-pgj2 (10.1038/S42003-019-0426-2 )
• 6YL4: soluble epoxide hydrolase in complex with 3-((r)-3-(1-hydroxyureido) but-1-yn-1-yl)-n-((s)-3-phenyl-3-(4-trifluoromethoxy)phenyl)propyl) benzamide (10.1021/ACS.JMEDCHEM.0C00561 )
• 7A7G: soluble epoxide hydrolase in complex with tk90 (10.1021/ACS.JMEDCHEM.0C02063 )
• 7EBA: co-crystal of kurarinone with seh (10.1073/PNAS.2118818119 )